vs
Four Corners Property Trust, Inc.（FCPT）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
再鼎医药的季度营收约是Four Corners Property Trust, Inc.的1.6倍（$127.1M vs $78.2M），再鼎医药同比增速更快（17.1% vs 9.4%），过去两年再鼎医药的营收复合增速更高（20.8% vs 8.4%）
Four Corners Property Trust是一家上市房地产投资信托公司，核心业务为收购、持有及运营高品质净租赁商业地产，资产以美国各地的餐厅与零售物业为主，租户多为经营表现稳定的消费赛道企业。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
FCPT vs ZLAB — 直观对比
营收规模更大
ZLAB
是对方的1.6倍
$78.2M
营收增速更快
ZLAB
高出7.8%
9.4%
两年增速更快
ZLAB
近两年复合增速
8.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $78.2M | $127.1M |
| 净利润 | $30.4M | — |
| 毛利率 | — | 51.0% |
| 营业利润率 | 55.3% | -54.6% |
| 净利率 | 38.8% | — |
| 营收同比 | 9.4% | 17.1% |
| 净利润同比 | 16.0% | — |
| 每股收益（稀释后） | $0.28 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FCPTZLAB
| Q1 26 | $78.2M | — | ||
| Q4 25 | $75.7M | $127.1M | ||
| Q3 25 | $74.1M | $115.4M | ||
| Q2 25 | $72.8M | $109.1M | ||
| Q1 25 | $71.5M | $105.7M | ||
| Q4 24 | $68.3M | $108.5M | ||
| Q3 24 | $66.8M | $101.8M | ||
| Q2 24 | $66.5M | $100.1M |
净利润FCPTZLAB
| Q1 26 | $30.4M | — | ||
| Q4 25 | $29.4M | — | ||
| Q3 25 | $28.8M | $-36.0M | ||
| Q2 25 | $27.9M | $-40.7M | ||
| Q1 25 | $26.2M | $-48.4M | ||
| Q4 24 | $26.2M | — | ||
| Q3 24 | $25.6M | $-41.7M | ||
| Q2 24 | $24.7M | $-80.3M |
毛利率FCPTZLAB
| Q1 26 | — | — | ||
| Q4 25 | — | 51.0% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 60.6% | ||
| Q1 25 | — | 63.6% | ||
| Q4 24 | — | 61.5% | ||
| Q3 24 | — | 64.1% | ||
| Q2 24 | — | 64.9% |
营业利润率FCPTZLAB
| Q1 26 | 55.3% | — | ||
| Q4 25 | — | -54.6% | ||
| Q3 25 | — | -42.3% | ||
| Q2 25 | — | -50.3% | ||
| Q1 25 | — | -53.3% | ||
| Q4 24 | — | -62.6% | ||
| Q3 24 | — | -66.6% | ||
| Q2 24 | — | -76.0% |
净利率FCPTZLAB
| Q1 26 | 38.8% | — | ||
| Q4 25 | 38.9% | — | ||
| Q3 25 | 38.9% | -31.2% | ||
| Q2 25 | 38.3% | -37.3% | ||
| Q1 25 | 36.6% | -45.8% | ||
| Q4 24 | 38.3% | — | ||
| Q3 24 | 38.3% | -40.9% | ||
| Q2 24 | 37.1% | -80.2% |
每股收益（稀释后）FCPTZLAB
| Q1 26 | $0.28 | — | ||
| Q4 25 | $0.27 | $-0.05 | ||
| Q3 25 | $0.28 | $-0.03 | ||
| Q2 25 | $0.28 | $-0.04 | ||
| Q1 25 | $0.26 | $-0.04 | ||
| Q4 24 | $0.27 | $-0.09 | ||
| Q3 24 | $0.27 | $-0.04 | ||
| Q2 24 | $0.27 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $29.6M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.7B | $715.5M |
| 总资产 | $3.0B | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FCPTZLAB
| Q1 26 | $29.6M | — | ||
| Q4 25 | $12.1M | $689.6M | ||
| Q3 25 | $6.7M | $717.2M | ||
| Q2 25 | $6.0M | $732.2M | ||
| Q1 25 | $22.3M | $757.3M | ||
| Q4 24 | $4.1M | $779.7M | ||
| Q3 24 | $44.5M | $616.1M | ||
| Q2 24 | $17.2M | $630.0M |
总债务FCPTZLAB
| Q1 26 | — | — | ||
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.2B | — |
股东权益FCPTZLAB
| Q1 26 | $1.7B | — | ||
| Q4 25 | $1.6B | $715.5M | ||
| Q3 25 | $1.5B | $759.9M | ||
| Q2 25 | $1.5B | $791.7M | ||
| Q1 25 | $1.4B | $810.8M | ||
| Q4 24 | $1.5B | $840.9M | ||
| Q3 24 | $1.4B | $667.7M | ||
| Q2 24 | $1.3B | $704.2M |
总资产FCPTZLAB
| Q1 26 | $3.0B | — | ||
| Q4 25 | $2.9B | $1.2B | ||
| Q3 25 | $2.8B | $1.2B | ||
| Q2 25 | $2.8B | $1.2B | ||
| Q1 25 | $2.7B | $1.2B | ||
| Q4 24 | $2.7B | $1.2B | ||
| Q3 24 | $2.6B | $985.3M | ||
| Q2 24 | $2.5B | $987.4M |
负债/权益比FCPTZLAB
| Q1 26 | — | — | ||
| Q4 25 | 0.74× | — | ||
| Q3 25 | 0.79× | — | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | 0.84× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | 0.84× | — | ||
| Q2 24 | 0.92× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-26.7M |
| 自由现金流率自由现金流/营收 | — | -21.0% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-158.9M |
8季度趋势，按日历期对齐
经营现金流FCPTZLAB
| Q1 26 | — | — | ||
| Q4 25 | $192.3M | $-26.0M | ||
| Q3 25 | $48.9M | $-32.0M | ||
| Q2 25 | $43.8M | $-31.0M | ||
| Q1 25 | $51.6M | $-61.7M | ||
| Q4 24 | $144.1M | $-55.8M | ||
| Q3 24 | $43.4M | $-26.8M | ||
| Q2 24 | $39.7M | $-42.2M |
自由现金流FCPTZLAB
| Q1 26 | — | — | ||
| Q4 25 | — | $-26.7M | ||
| Q3 25 | — | $-35.0M | ||
| Q2 25 | — | $-33.9M | ||
| Q1 25 | — | $-63.2M | ||
| Q4 24 | — | $-58.4M | ||
| Q3 24 | — | $-28.2M | ||
| Q2 24 | — | $-42.9M |
自由现金流率FCPTZLAB
| Q1 26 | — | — | ||
| Q4 25 | — | -21.0% | ||
| Q3 25 | — | -30.4% | ||
| Q2 25 | — | -31.1% | ||
| Q1 25 | — | -59.9% | ||
| Q4 24 | — | -53.8% | ||
| Q3 24 | — | -27.7% | ||
| Q2 24 | — | -42.9% |
资本支出强度FCPTZLAB
| Q1 26 | — | — | ||
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 1.3% | ||
| Q2 24 | — | 0.7% |
现金转化率FCPTZLAB
| Q1 26 | — | — | ||
| Q4 25 | 6.53× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.57× | — | ||
| Q1 25 | 1.97× | — | ||
| Q4 24 | 5.51× | — | ||
| Q3 24 | 1.70× | — | ||
| Q2 24 | 1.61× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FCPT
| Rental revenue | $69.8M | 89% |
| Restaurant revenue | $8.4M | 11% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
